Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1994 | 2 |
1995 | 1 |
1996 | 1 |
1997 | 1 |
1998 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Pharmaceutical development of a parenteral formulation of the investigational anticancer drug clanfenur.
PDA J Pharm Sci Technol. 1997 Mar-Apr;51(2):89-95.
PDA J Pharm Sci Technol. 1997.
PMID: 9146040
Pharmaceutical development of a parenteral formulation of the novel anti-tumor agent carzelesin (U-80,244).
Jonkman-de Vries JD, de Graaff-Teulen MJ, Henrar RE, Kettenes-van den Bosch JJ, Bult A, Beijnen JH.
Jonkman-de Vries JD, et al.
Invest New Drugs. 1994;12(4):303-14. doi: 10.1007/BF00873045.
Invest New Drugs. 1994.
PMID: 7775131
Item in Clipboard
The influence of formulation excipients on the stability of the novel antitumor agent carzelesin (U-80,244).
Jonkman-De Vries JD, Rosing H, Henrar RE, Bult A, Beijnen JH.
Jonkman-De Vries JD, et al.
PDA J Pharm Sci Technol. 1995 Nov-Dec;49(6):283-8.
PDA J Pharm Sci Technol. 1995.
PMID: 8581459
Item in Clipboard
Pharmaceutical development of a parenteral lyophilized formulation of the investigational antitumor neuropeptide antagonist [Arg6, D-Trp7,9, MePhe8]-Substance P [6-11].
Jonkman-de Vries JD, Rosing H, Talsma H, Henrar RE, Kettenes-van den Bosch JJ, Bult A, Beijnen JH.
Jonkman-de Vries JD, et al.
Invest New Drugs. 1998;16(2):99-111. doi: 10.1023/a:1006041024109.
Invest New Drugs. 1998.
PMID: 9848573
Item in Clipboard
Pharmaceutical development of a parenteral lyophilized formulation of the novel indoloquinone antitumor agent EO9.
Jonkman-de Vries JD, Talsma H, Henrar RE, Kettenes-van den Bosch JJ, Bult A, Beijnen JH.
Jonkman-de Vries JD, et al.
Cancer Chemother Pharmacol. 1994;34(5):416-22. doi: 10.1007/BF00685567.
Cancer Chemother Pharmacol. 1994.
PMID: 8070009
Item in Clipboard
Purity determinations in the bulk drug of the novel indoloquinone antitumor agent EO9.
Jonkman-de Vries JD, Kettenes-van den Bosch JJ, Henrar RE, Bult A, Beijnen JH.
Jonkman-de Vries JD, et al.
Invest New Drugs. 1996;14(2):181-91. doi: 10.1007/BF00210789.
Invest New Drugs. 1996.
PMID: 8913839
Item in Clipboard
Cite
Cite